Clearance of amyloid beta-peptide from brain: transport or metabolism?

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Nature Medicine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10888892
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Understanding monocyte-driven neuroinflammation in Alzheimer’s disease using human cortical organoid microphysiological systems

  2025cites this paper
• Cerebral Amyloid Deposition With 18F‐Florbetapir PET Mediates Retinal Vascular Density and Cognitive Impairment in Alzheimer's Disease

  2025cites this paper
• Traumatic brain injury and neurodegenerative diseases: the role of axonal injury and amyloid-β.

  2025cites this paper
• Overview of Preclinical and Clinical Trials of Nanoparticles for the Treatment of Brain Metastases

  2025cites this paper
• Characterizing Protein Concentration in Cerebrospinal Fluid with T2 Component Analysis

  2024cites this paper
• Sensory Gamma Entrainment: Impact on amyloid protein and Therapeutic mechanism.

  2023cites this paper
• Altered dynamics of glymphatic flow in a mature-onset Tet-off APP mouse model of amyloidosis

  2023cites this paper
• Uncovering the System Vulnerability and Criticality of Human Brain Under Dynamical Neuropathological Events in Alzheimer’s Disease

  2022cites this paper
• Angiotensin II type 1 receptor deficiency protects against the impairment of blood–brain barrier in a mouse model of traumatic brain injury

  2021cites this paper
• Impact of age, hypercholesterolemia, and the vitamin D receptor on brain endogenous β‐amyloid peptide accumulation in mice

  2021cites this paper
• Modulation of the Blood–Brain Barrier for Drug Delivery to Brain

  2021cites this paper
• Measuring Amyloid‐β Peptide Concentrations in Murine Brain with Improved ELISA Assay

  2021cites this paper
• Inhibition of Aquaporin 4 Decreases Amyloid Aβ40 Drainage Around Cerebral Vessels

  2020cites this paper
• Further understanding the connection between Alzheimer's disease and Down syndrome

  2020cites this paper
• Impaired glymphatic function and clearance of tau in an Alzheimer’s disease model

  2020cites this paper
• Amyloid beta hypothesis in Alzheimer's disease: Major culprits and recent therapeutic strategies.

  2020cites this paper
• Molecular Labeling of DNA Amyloid Sensor with Plasma, and the Glycemic Factor, for Photonic Detection of Alzheimer's in Blood

  2020cites this paper
• The multi-faceted impact of methamphetamine on Alzheimer's disease: From a triggering role to a possible therapeutic use.

  2020cites this paper
• Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment

  2020cites this paper
• Biomarkers Related to Endothelial Dysfunction and Vascular Cognitive Impairment: A Systematic Review

  2020cites this paper
• Physical Exercise May Increase Plasma Concentration of High-Density Lipoprotein-Cholesterol in Patients With Alzheimer’s Disease

  2020cites this paper
• Stem cell therapy for Alzheimer's disease

  2020cites this paper
• Human Amyloid-β40 Kinetics after Intravenous and Intracerebroventricular Injections and Calcitriol Treatment in Rats In Vivo

  2020cites this paper
• Secretory proteostasis of the retinal pigmented epithelium: Impairment links to age-related macular degeneration.

  2020cites this paper
• Human Amyloid- b 40 Kinetics after Intravenous and Intracerebroventricular Injections and Calcitriol Treatment in Rats In Vivo s

  2020cites this paper
• An optimized method for purification of whole brain-derived extracellular vesicles reveals insight into neurodegenerative processes in a mouse model of Alzheimer’s disease.

  2020cites this paper
• Neural stem cell therapy for neurovascular injury in Alzheimer's disease.

  2019cites this paper
• LRP1-upregulated nanoparticles for efficiently conquering the blood-brain barrier and targetedly suppressing multifocal and infiltrative brain metastases.

  2019cites this paper
• Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer’s disease mouse model with suppression of glymphatic clearance

  2019cites this paper
• Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It?

  2019cites this paper
• Decrease in HDL-C is Associated with Age and Household Income in Adults from the Korean National Health and Nutrition Examination Survey 2017: Correlation Analysis of Low HDL-C and Poverty

  2019cites this paper
• Interleukin-4 affects microglial autophagic flux

  2019cites this paper
• HDL from an Alzheimer's disease perspective

  2019cites this paper
• Recent Insights on Alzheimer’s Disease Originating from Yeast Models

  2018cites this paper
• Neuroprotective effect of formononetin in ameliorating learning and memory impairment in mouse model of Alzheimer’s disease

  2018cites this paper
• Magnesium Reduces Blood-Brain Barrier Permeability and Regulates Amyloid-β Transcytosis

  2018cites this paper
• Effect of Buyanghuanwu decoction on hippocampal morphology and expression of LRP 1 and ApoJ in APP / PS 1 mice

  2018cites this paper
• An optimized method for enrichment of whole brain-derived extracellular vesicles reveals insight into neurodegenerative processes in a mouse model of Alzheimer's disease.

  2018cites this paper
• Omega‐3 polyunsaturated fatty acids promote amyloid‐β clearance from the brain through mediating the function of the glymphatic system

  2017cites this paper
• Lipocalin 2 and Matrix-Metalloproteinase-9 in Alzheimer ’ s Disease

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) Targeting Neuroinflammation to Treat Alzheimer ' s Disease

  2017cites this paper
• Intermittent Fasting Protects against Alzheimer’s Disease Possible through Restoring Aquaporin-4 Polarity

  2017cites this paper
• Voluntary Exercise Promotes Glymphatic Clearance of Amyloid Beta and Reduces the Activation of Astrocytes and Microglia in Aged Mice

  2017cites this paper
• Targeting Neuroinflammation to Treat Alzheimer’s Disease

  2017cites this paper
• Amyloid beta: structure, biology and structure-based therapeutic development

  2017cites this paper
• Role of P-glycoprotein in mediating rivastigmine effect on amyloid-β brain load and related pathology in Alzheimer's disease mouse model.

  2016influential citation
• Is Beta-Amyloid Accumulation a Cause or Consequence of Alzheimer's Disease?

  2016cites this paper
• Reference tissue normalization in longitudinal 18F-florbetapir positron emission tomography of late mild cognitive impairment

  2016cites this paper
• Blood-Brain Barrier ABC-transporter P-glycoprotein in Alzheimer's Disease: Still a Suspect?

  2016cites this paper
• High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity

  2016cites this paper
• 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport.

  2016cites this paper
• Modulating Role of TTR in Aβ Toxicity, from Health to Disease

  2016cites this paper
• Effect of mouse strain as a background for Alzheimer's disease models on the clearance of amyloid-β.

  2016cites this paper
• Cerebrospinal Fluid Dynamics and the Pathophysiology of Hydrocephalus: New Concepts.

  2016cites this paper
• Extra-virgin olive oil attenuates amyloid-β and tau pathologies in the brains of TgSwDI mice.

  2015cites this paper
• Common Pesticide, Dichlorodiphenyltrichloroethane (DDT), Increases Amyloid-β Levels by Impairing the Function of ABCA1 and IDE: Implication for Alzheimer’s Disease

  2015cites this paper
• Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer’s Disease

  2015cites this paper
• Mechanism of Nucleated Conformational Conversion of Aβ42.

  2015cites this paper
• Can oral infection be a risk factor for Alzheimer's disease?

  2015cites this paper
• 6-Phenoxy-2-phenylbenzoxazoles, novel inhibitors of receptor for advanced glycation end products (RAGE).

  2015cites this paper
• Clearance systems in the brain-implications for Alzheimer disease.

  2015cites this paper
• Kaolin-induced chronic hydrocephalus accelerates amyloid deposition and vascular disease in transgenic rats expressing high levels of human APP

  2015cites this paper
• Age-Related Decline in Brain and Hepatic Clearance of Amyloid-Beta is Rectified by the Cholinesterase Inhibitors Donepezil and Rivastigmine in Rats.

  2015cites this paper
• Novel targets for Alzheimer's disease treatment

  2014cites this paper
• Amyloid-beta accumulation, neurogenesis, behavior, and the age of rats.

  2014cites this paper
• Novel targets for Alzheimer's disease treatment

  2014cites this paper
• 1α,25-Dihydroxyvitamin D3 Reduces Cerebral Amyloid-β Accumulation and Improves Cognition in Mouse Models of Alzheimer's Disease

  2014cites this paper
• Amyloid‐β efflux from the central nervous system into the plasma

  2014cites this paper
• Intracellular Aβ pathology and early cognitive impairments in a transgenic rat overexpressing human amyloid precursor protein: a multidimensional study

  2014cites this paper
• Implications of Human Umbilical Cord Blood Cells: An Immunotherapeutic Strategy for Alzheimer's Disease

  2014cites this paper
• Cerebrospinal fluid physiology: visualization of cerebrospinal fluid dynamics using the magnetic resonance imaging Time-Spatial Inversion Pulse method

  2014cites this paper
• Blood Platelets in the Progression of Alzheimer’s Disease

  2014cites this paper
• Docosahexaenoic Acid Reduces Amyloid-β Induced Toxicity in Cells of the Neurovascular Unit

  2013cites this paper
• Sevoflurane alters the expression of receptors and enzymes involved in Aβ clearance in rats

  2013cites this paper
• Quercetin protects against the Aβ(25-35)-induced amnesic injury: involvement of inactivation of rage-mediated pathway and conservation of the NVU.

  2013cites this paper
• In Vitro Investigation of Amyloid-β Hepatobiliary Disposition in Sandwich-Cultured Primary Rat Hepatocytes

  2013influential citation
• Olive-oil-derived oleocanthal enhances β-amyloid clearance as a potential neuroprotective mechanism against Alzheimer's disease: in vitro and in vivo studies.

  2013cites this paper
• Cardiovascular and cerebrovascular physiological measurements in clinical practice and prognostics in geriatric patients

  2013cites this paper
• Metabolism of amyloid β peptide and pathogenesis of Alzheimer’s disease

  2013cites this paper
• Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease.

  2013cites this paper
• Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease

  2013cites this paper
• Blood–brain-barriers in aging and in Alzheimer’s disease

  2013cites this paper
• Endogenous Secretory Receptor for Advanced Glycation End-Products Inhibits Amyloid-β1-42 Uptake into Mouse Brain

  2012cites this paper
• Is RAGE still a therapeutic target for Alzheimer's disease?

  2012cites this paper
• Relationships between the amyloid precursor protein and its various proteolytic fragments and neuronal systems

  2012cites this paper
• The role of inflammatory processes in Alzheimer’s disease

  2012cites this paper
• Oscillations in cerebral blood flow and cortical oxygenation in Alzheimer's disease.

  2012cites this paper
• Enhanced Brain Amyloid-β Clearance by Rifampicin and Caffeine as a Possible Protective Mechanism Against Alzheimer's Disease

  2012cites this paper
• Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.

  2012influential citation
• 1α,25‐Dihydroxyvitamin D3‐liganded vitamin D receptor increases expression and transport activity of P‐glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells

  2012cites this paper
• Monocytes and Alzheimer’s disease

  2011cites this paper
• O1‐07‐04: Blood‐brain barrier p‐glycoprotein function in Alzheimer's disease

  2011cites this paper
• LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier.

  2011cites this paper
• Intranasal delivery of therapeutic proteins for neurological diseases

  2011influential citation
• Association of Plasma Aß Peptides with Blood Pressure in the Elderly

  2011cites this paper
• Modeling Effect of a γ-Secretase Inhibitor on Amyloid-β Dynamics Reveals Significant Role of an Amyloid Clearance Mechanism

  2011cites this paper
• A hyperlipidemic diet induces structural changes in cerebral blood vessels.

  2011cites this paper
• Selective Antihypertensive Dihydropyridines Lower Aβ Accumulation by Targeting both the Production and the Clearance of Aβ across the Blood-Brain Barrier

  2011cites this paper
• Impairments in Brain-to-Blood Transport of Amyloid-β and Reabsorption of Cerebrospinal Fluid in an Animal Model of Alzheimer's Disease are Reversed by Antisense Directed Against Amyloid-β Protein Precursor

  2011cites this paper
• Cerebral Amyloid Angiopathy: A Systematic Review

  2011cites this paper